News

Published on 29 Nov 2021 on Zacks via Yahoo Finance

Here's Why You Should Hold on to Globus Medical (GMED) for Now


Article preview image

Globus Medical, Inc. GMED is gaining from strength in the Enabling Technologies arm. The company exited the third quarter with better-than-expected earnings. The robust performance by ExcelsiusGPS platforms buoys optimism. A strong solvency position is an added advantage. However, escalating expenses and foreign exchange woes raise apprehension.

Over the past year, this Zacks Rank #3 (Hold) stock has gained 6.4% compared with 8.9% growth of the industry and 27.5% rise of the S&P 500 composite.

The renowned medical device company has a market capitalization of $6.49 billion. Its earnings for the third-quarter 2021 surpassed the Zacks Consensus Estimate by 11.1%.

NYSE.WST price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now

West Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietar...

Zacks via Yahoo Finance 14 Mar 2024

Insider Sell: VP, Chief Accounting Officer Chad Winters Sells Shares of West Pharmaceutical ...

West Pharmaceutical Services Inc (NYSE:WST), a global leader in the design and production of cont...

GuruFocus.com via Yahoo Finance 12 Mar 2024

Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic...

Key Insights West Pharmaceutical Services' estimated fair value is US$295 based on 2 Stage Free C...

Simply Wall St. via Yahoo Finance 12 Mar 2024

West Pharmaceutical Services Inc President and CEO Eric Green Sells Company Shares

Eric Green, President, CEO, and Board Chair of West Pharmaceutical Services Inc (NYSE:WST), has s...

GuruFocus.com via Yahoo Finance 1 Mar 2024

Insider Sell: SVP, Chief Technology Officer Silji Abraham Sells 7,012 Shares of West ...

Silji Abraham, SVP, Chief Technology Officer of West Pharmaceutical Services Inc (NYSE:WST), has ...

GuruFocus.com via Yahoo Finance 27 Feb 2024

Decoding West Pharmaceutical Services Inc (WST): A Strategic SWOT Insight

West Pharmaceutical Services Inc (NYSE:WST) exhibits robust financial performance with a strong f...

GuruFocus.com via Yahoo Finance 22 Feb 2024

West Pharmaceutical Services (WST) Fell on Reduced Full Year Guidance

Conestoga Capital Advisors, an asset management company, released its “SMid Cap Strategy” fourth-...

Insider Monkey via Yahoo Finance 19 Feb 2024

Analysts Have Lowered Expectations For West Pharmaceutical Services, Inc. (NYSE:WST) After Its...

There's been a notable change in appetite for West Pharmaceutical Services, Inc. (NYSE:WST) share...

Simply Wall St. via Yahoo Finance 18 Feb 2024

West Pharmaceutical Services' (NYSE:WST) earnings growth rate lags the 28% CAGR delivered to...

West Pharmaceutical Services, Inc. (NYSE:WST) shareholders might be concerned after seeing the sh...

Simply Wall St. via Yahoo Finance 16 Feb 2024

West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2023 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2023 Earnings Call Transcript February 15, 2024 ...

Insider Monkey via Yahoo Finance 16 Feb 2024